Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528424 | Clinical Therapeutics | 2017 | 12 Pages |
Abstract
We found no differences in patient characteristics between patients with and without LDL-C measurements after being newly diagnosed with CAD. Performance and frequency of LDL-C measurements were clearly associated with better, higher frequency of intensification of statin medication, lower achieved LDL-C levels, and a higher proportion of patients achieving the LDL-C goal of <70 mg/dL. These results suggest an important role of LDL-C measurements for secondary prevention after the initial diagnosis of CAD.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Christoph MD, Moritz MD, Nils Staebe, Julian MD, Rebecca Kohsiack, Francisco PhD, Niklas MD, Mahir MD, Tanja PhD, Christoph MD, Benedikt MD, Dirk MD, Karsten MD, Stefan MD, Fabian J. MD, Renate B. MD, MSc,